We are live on ! Find out more
IART icon

Integra LifeSciences

131 hedge funds and large institutions have $893M invested in Integra LifeSciences in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

13% more capital invested

Capital invested by funds: $791M → $893M (+$101M)

2% more funds holding

Funds holding: 129131 (+2)

9% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 46

90% less call options, than puts

Call options by funds: $8K | Put options by funds: $81K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
131
Holders Change
+2
Holders Change %
+1.55%
% of All Funds
4.25%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
16
Increased
50
Reduced
46
Closed
10
Calls
$8K
Puts
$81K
Net Calls
-$73K
Net Calls Change
-$351K
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$1.89M -$1.11M -69,071 -38%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$1.86M +$267K +16,636 +17%
New York State Teachers Retirement System (NYSTRS)
53
New York State Teachers Retirement System (NYSTRS)
New York
$1.82M -$31.4K -1,957 -2%
JP Morgan Chase
54
JP Morgan Chase
New York
$1.69M +$76.5K +4,766 +5%
ACM
55
American Capital Management
New York
$1.69M
Zurich Cantonal Bank
56
Zurich Cantonal Bank
Switzerland
$1.61M
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1.45M +$42.1K +2,625 +3%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$1.37M -$30.2K -1,882 -2%
Goldman Sachs
59
Goldman Sachs
New York
$1.22M +$203K +12,670 +21%
AIG
60
American International Group
New York
$1.16M -$80 -5 -0%
TA
61
Teachers Advisors
New York
$1.13M +$50.9K +3,173 +5%
KeyBank National Association
62
KeyBank National Association
Ohio
$1.08M +$1.05M +65,629 New
Federated Hermes
63
Federated Hermes
Pennsylvania
$953K -$72K -4,489 -7%
Comerica Bank
64
Comerica Bank
Texas
$945K +$24.4K +1,522 +3%
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$940K
BG
66
BlackRock Group
United Kingdom
$911K +$147K +9,187 +20%
Bank of America
67
Bank of America
North Carolina
$904K -$746K -46,483 -46%
TPSF
68
Texas Permanent School Fund
Texas
$874K -$37.3K -2,326 -4%
State of Tennessee, Department of Treasury
69
State of Tennessee, Department of Treasury
Tennessee
$857K +$836K +52,110 New
Millennium Management
70
Millennium Management
New York
$805K +$785K +48,929 New
ASRS
71
Arizona State Retirement System
Arizona
$738K +$19.6K +1,223 +3%
Barclays
72
Barclays
United Kingdom
$720K -$75K -4,671 -10%
Swiss National Bank
73
Swiss National Bank
Switzerland
$720K -$62.8K -3,914 -8%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$674K -$36.7K -2,290 -5%
BC
75
Burney Company
Virginia
$638K

IART Hedge Fund Activity: Q3 2013 in Review

131 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2013, worth a combined $893M — up 13% from $791M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IART positions and 10 closed out — a net gain of 6 holders — while 50 added to existing stakes and 46 trimmed.

The largest buyer was Invesco, adding an estimated $6.77M. The largest seller was Broadfin Capital, cutting an estimated $11.1M.

  • 131 institutional investors held Integra LifeSciences (IART) as of Q3 2013, up from 129 in Q2 2013.
  • Funds reported $893M of Integra LifeSciences stock for Q3 2013, up 13% quarter-over-quarter.
  • 16 funds opened new Integra LifeSciences positions in Q3 2013 and 10 closed out, a net change of +6 holders.
  • The largest Integra LifeSciences buyer in Q3 2013 was Invesco, an estimated $6.77M added.
  • The largest Integra LifeSciences seller in Q3 2013 was Broadfin Capital, an estimated $11.1M sold.

Based on aggregated 13F filings for Q3 2013.